Mission Statement, Vision, & Core Values (2024) of Olink Holding AB (publ) (OLK)

An Overview of Olink Holding AB (publ) (OLK)

General Summary of Olink Holding AB

Olink Holding AB (publ), founded in 2016, is a global leader in the field of proteomics, focusing on enabling biomarker discovery through its innovative platform, Olink Explore. The company specializes in providing products and services that facilitate the analysis of protein biomarkers, catering to the needs of researchers and healthcare professionals. Olink's offerings include a range of multiplex immunoassays and data analysis solutions, allowing for high-throughput proteomic analysis.

As of 2024, Olink has reported sales of approximately SEK 1.3 billion, reflecting a significant increase from the previous year, driven by the growing demand for proteomics in clinical research and diagnostics.

Company's Financial Performance in the Latest Financial Reports

In the latest financial report for Q1 2024, Olink Holding AB announced a record-breaking revenue of SEK 350 million, a remarkable increase of 45% year-over-year. This growth was largely attributed to the success of its main product lines, with the Olink Explore platform accounting for SEK 220 million of the total revenue. The company demonstrated robust expansion across key markets, particularly in North America and Europe, where sales increased by 50% and 40%, respectively.

Introduction to Company as a Leader in the Industry

Olink Holding AB stands out as one of the leading companies in the proteomics industry, thanks to its dedicated focus on advancing the science of protein biomarker discovery. The company’s innovative technology has positioned it at the forefront of the market, with a growing portfolio of high-quality products and services that are essential in clinical and research settings. Olink's strategic partnerships and collaborations with renowned academic institutions and pharmaceutical companies further enhance its reputation and contribute to its success.

For those interested in exploring more about Olink and understanding the drivers of its success, additional information follows.

Mission Statement of Olink Holding AB (publ) (OLK)

Mission Statement Overview

The mission statement of Olink Holding AB (publ) encapsulates the essence of the company's commitment to advancing proteomics technology and enhancing the understanding of biology and diseases.

Significantly, this mission statement serves as a guiding principle for the company's long-term goals, emphasizing the pursuit of innovation, excellence, and value creation for stakeholders.

Core Component 1: Innovation

Olink’s first core component is focused on innovation. This is evident in their continuous investment in research and development, which amounted to €37.1 million in 2022, constituting approximately 38% of the company’s total revenue.

This dedication towards innovation is demonstrated by their novel protein biomarker discovery platform, which enables researchers to gain insights into various diseases.

Core Component 2: Quality

The second core component is quality. Olink emphasizes high-quality products and services, targeting accuracy and reliability in proteomic analysis. In a 2023 customer satisfaction survey, 92% of clients rated Olink’s products as meeting or exceeding expectations for quality.

This focus on quality is supported by their stringent quality control protocols, ensuring that every product adheres to high standards.

Core Component 3: Value Creation

The third core component revolves around value creation for customers and stakeholders. In 2022, Olink reported a revenue increase of 50%, amounting to €97.4 million, highlighting the success in delivering value through their innovative solutions.

Moreover, the strategic partnerships fostered by Olink have led to collaborative projects that enhance product offerings, further enriching the value delivered to customers.

Vision Statement of Olink Holding AB (publ) (OLK)

Vision Statement Overview

The vision statement of Olink Holding AB (publ) in 2024 articulates its direction and aspirations within the field of protein detection and analysis. The company aims to revolutionize proteomics to enhance healthcare through innovative products and services.

Future Aspirations

As per their vision for 2024, Olink focuses on expanding its reach within the life sciences sector, emphasizing the following key aspirations:

• To be recognized as a global leader in proteomics research.
• To significantly enhance disease understanding and therapeutic development.
• To foster strategic collaborations that amplify innovation.

Market Positioning

Olink aims to solidify its position in the market through the incorporation of cutting-edge technology, such as:

• Utilizing its Proximity Extension Assay (PEA) technology.
• Expanding its product offerings to include new biomarkers.
• Targeting an increase in global market share by at least 15% by 2025.

Commitment to Innovation

Olink's vision underscores an unwavering commitment to innovation, focusing on:

• Increasing R&D investment to at least 20% of revenue.
• Launching 10 new products in the next 2 years.
• Enhancing technological capabilities through partnerships and acquisitions.

Financial Goals

The financial goals outlined in the vision statement reflect Olink's focus on sustainable growth and profitability:

• Achieving revenue growth of approximately 25% annually.
• Maintaining gross margins above 70%.
• Projected total revenue of $300 million by the end of 2024.

Table of Key Financial Metrics

Strategic Partnerships

In alignment with its vision, Olink emphasizes forging strategic partnerships aimed at:

• Collaborating with academic institutions for innovative research.
• Partnering with pharmaceutical companies for drug development.
• Engaging with technological firms to enhance product capabilities.

Global Outreach

Olink’s vision includes a strong emphasis on international expansion, targeting key markets such as:

• United States
• Europe
• Asia-Pacific

The company aims to enter at least three new countries by the end of 2024.

Sustainability Initiatives

Olink is committed to integrating sustainability into its vision by:

• Reducing carbon footprint by 30% by 2025.
• Implementing sustainable sourcing practices.
• Promoting a culture of environmental responsibility within the organization.

Core Values of Olink Holding AB (publ) (OLK)

Innovation

Innovation is at the heart of Olink Holding AB’s operations, driving the advancement of proteomics technologies. The company invests heavily in research and development, allocating approximately $10 million annually to foster groundbreaking discoveries and innovative products.

In 2024, Olink launched its new product line, the Olink Explore, which enables detailed protein analysis with a throughput of over 1,000 samples per day. This product has expanded their market share by 15% in the last fiscal year. Furthermore, Olink's collaboration with leading academic institutions has resulted in over 50 peer-reviewed publications that underline the significance of their innovative technologies.

Integrity

Integrity governs Olink's business practices and interactions with stakeholders. The company has adhered to a strict code of conduct, achieving 100% compliance in its 2024 internal audits. Olink's transparency is reflected in its quarterly financial disclosures, providing detailed analyses of revenues, which totaled $80 million in 2023, marking a 20% increase from the previous year.

In an effort to uphold integrity, Olink has implemented a whistleblower policy and training programs, ensuring that all employees are aware and able to report unethical behavior. As of 2024, the company reported zero incidents of ethical violations.

Collaboration

Collaboration is essential to Olink's success, fostering partnerships that enhance scientific research and product development. In 2024, the company partnered with over 40 pharmaceutical companies to accelerate drug development processes. This collaborative approach has reduced project timelines by an average of 30%.

Olink's annual conference, aimed at bringing together researchers and industry leaders, witnessed attendance from over 500 participants in 2023, showcasing the importance of collaborative efforts in advancing proteomics.

Customer Commitment

Customer Commitment is foundational for Olink, focusing on delivering exceptional value and service. Customer satisfaction surveys conducted in 2023 indicated a satisfaction rate of 95%, with 80% of clients stating they would recommend Olink products to others.

The company offers extensive support programs, including dedicated customer service representatives and comprehensive training for new clients, resulting in a 25% decrease in response times in 2024. Olink also achieved a net promoter score (NPS) of 70, reflecting robust customer loyalty.

Social Responsibility

Social Responsibility is a pivotal value for Olink, which believes in giving back to the community and promoting sustainable practices. In 2023, Olink allocated $2 million to various health initiatives, improving access to protein research in underprivileged areas.

The company has implemented a sustainability program aimed at reducing its carbon footprint by 50% by 2025. As of 2024, Olink has already achieved a 30% reduction in emissions through energy-efficient practices at its manufacturing facilities.